Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Concentric Medical Merci

This article was originally published in The Gray Sheet

Executive Summary

Embolism retrieval system achieved cerebral revascularization in 51% of patients in the 81-patient, Phase I MERCI trial (41/81). The success rate, based on immediate post-procedure angiography, is a more accurate figure than the previously reported 81% rate that was based on 27 patients monitored with CT 24 hours post-procedure, according to the company (1"The Gray Sheet" Jan. 5, 2004, p. 7)...

You may also be interested in...



Merci Clot Retrieval Catheter Data Show 47% Event-Free Revascularization

Concentric Medical's Merci Retriever embolic retrieval system 510(k) data show a 38% mortality rate in stroke patients versus 27% in the placebo group

Concentric Medical’s Merci Cerebral Clot Remover Set For February Panel

Concentric Medical will present neurological function data for its Merci embolic retrieval system to FDA's Neurological Devices Advisory Panel Feb. 23

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT019641

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel